Doyle Wealth Management Novo Nordisk A S Transaction History

Doyle Wealth Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 05, 2019	SELL	$47.54 - $53.43 $53,054 - $59,627	-1,116 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$46.79 - $52.47 $52,217 - $58,556	1,116 New	1,116 $57,000
Q1 2019 May 13, 2019	SELL	$46.36 - $52.63 $23,180 - $26,315	-500 Closed	0 $0
Q4 2018 Feb 08, 2019	BUY	$41.54 - $47.25 $20,770 - $23,625	500 New	500 $23,000

1,928

318M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $178B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Doyle Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Doyle Wealth Management with notifications on news.